Profile data is unavailable for this security.
About the company
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray) therapy in the United States for the treatment of depressive disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The Company operates a network of outpatient mental health service centers that specialize in Treatment across the United States. It offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The Company owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.
- Revenue in USD (TTM)72.49m
- Net income in USD-52.54m
- Incorporated2018
- Employees629.00
- LocationGreenbrook Tms Inc890 Yonge St 7th FloorTORONTO M4W 3P4CanadaCAN
- Phone+1 (416) 322-9700
- Fax+1 (416) 322-9700
- Websitehttps://www.greenbrooktms.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mitesco Inc | 0.00 | -10.91m | 1.72m | 3.00 | -- | -- | -- | -- | -1.91 | -1.94 | 0.00 | -2.60 | 0.00 | -- | -- | 0.00 | -10,172.81 | -246.54 | -- | -- | -- | -- | -- | -29,214.62 | -- | -0.1207 | -- | -- | -- | -- | -59.12 | -- | -- | -- |
| IMAC Holdings Inc | 0.00 | -5.63m | 1.88m | 2.00 | -- | -- | -- | -- | -5.04 | -5.46 | 0.00 | -1.08 | 0.00 | -- | 0.00 | 0.00 | -166.65 | -48.88 | -1,050.71 | -70.25 | -- | -- | -- | -97.63 | -- | -14.97 | -- | -- | -- | -- | 45.27 | -- | -- | -- |
| avVaa World Health Care Products Inc | 39.74k | 49.55k | 2.13m | 2.00 | 73.33 | -- | 42.91 | 53.50 | 0.00003 | 0.00003 | 0.00002 | -0.0069 | 0.8149 | -- | 9.63 | -- | 101.60 | 2,695.88 | -- | -- | 95.92 | 80.55 | 124.69 | 6,316.05 | -- | -- | -- | 0.00 | 142.40 | -12.09 | 159.21 | -- | -- | -- |
| CompuMed Inc | 1.78m | -151.00k | 2.71m | 8.00 | -- | 20.85 | -- | 1.53 | -0.1337 | -0.1337 | 1.58 | 0.0997 | 2.38 | 36.71 | 4.83 | -- | -19.92 | -46.77 | -48.38 | -76.78 | 50.42 | 57.04 | -8.38 | -25.84 | 0.9493 | -2.93 | 0.7744 | -- | -1.73 | -5.71 | 64.41 | -- | -18.75 | -- |
| Assure Holdings Corp | 149.00k | -22.55m | 2.81m | 95.00 | -- | -- | -- | 18.88 | -1.09 | -2.16 | 0.0244 | -2.24 | 0.0116 | -- | 0.0199 | 1,568.42 | -176.09 | -35.15 | -- | -46.37 | -1,406.71 | 37.14 | -15,132.21 | -116.06 | -- | -6.11 | -- | -- | -45.86 | -55.62 | 6.19 | -- | -- | -- |
| Ethema Health Corp | 5.35m | 957.28k | 2.98m | 65.00 | 3.48 | -- | 2.37 | 0.5581 | 0.0002 | 0.0002 | 0.0014 | -0.0018 | 0.5885 | -- | 11.88 | 82,231.23 | 8.90 | -37.68 | -- | -- | -- | -- | 15.12 | -94.87 | -- | -1.08 | 4.99 | -- | 10.87 | 65.34 | 652.41 | -- | 74.97 | -- |
| QHSLab Inc | 1.41m | -468.37k | 3.06m | 4.00 | -- | -- | -- | 2.18 | -0.0499 | -0.0499 | 0.1496 | -0.0386 | 0.7744 | 15.98 | 23.66 | 352,250.00 | -25.74 | -51.17 | -- | -197.31 | 56.32 | -- | -33.24 | -65.10 | 0.0637 | -1.04 | 1.27 | -- | 13.34 | -- | 52.98 | -- | -- | -- |
| Greenbrook TMS Inc | 72.49m | -52.54m | 3.31m | 629.00 | -- | -- | -- | 0.0456 | -1.24 | -1.24 | 1.71 | -2.45 | 0.9471 | -- | 6.22 | -- | -69.41 | -68.51 | -113.55 | -106.45 | 25.92 | 38.65 | -73.29 | -76.82 | -- | -2.40 | 136.38 | -- | 10.42 | 28.26 | 44.21 | -- | -54.79 | -- |
| Biocorrx Inc | 52.35k | -3.99m | 4.52m | 5.00 | -- | -- | -- | 86.30 | -0.464 | -0.464 | 0.0061 | -1.21 | 0.102 | -- | 0.9969 | -- | -778.76 | -291.68 | -- | -- | 44.64 | 67.13 | -7,635.86 | -3,208.40 | -- | -3.49 | -- | -- | -58.31 | -25.04 | 13.79 | -- | -- | -- |
| Interpace Biosciences Inc | 40.66m | 1.25m | 4.90m | 108.00 | 4.00 | -- | 2.48 | 0.1206 | 0.2802 | 0.2022 | 9.27 | -3.34 | 2.90 | 14.32 | 8.37 | 376,481.50 | 8.95 | -38.19 | -- | -69.73 | 59.02 | 49.44 | 3.08 | -41.01 | 0.4355 | 3.11 | -- | -- | 26.31 | 12.93 | 118.96 | -- | 0.9184 | -- |
| Holder | Shares | % Held |
|---|---|---|
| AdvisorShares Investments LLCas of 07 Jun 2024 | 1.11m | 2.38% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 19.90k | 0.04% |
| KJ Harrison & Partners, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |
| Citadel Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| TD Securities, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |
| Virtu Americas LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| RBC Dominion Securities, Inc. (Investment Management)as of 31 Mar 2024 | 0.00 | 0.00% |
| Financial Perspectives, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |
